S. Karger AG

SHERPA: Unknown

People

  1. Bodei
    Bodei
  2. Drilon
    Drilon
  3. Motzer
    Motzer
  4. Abou-Alfa
    Abou-Alfa
  5. Chaganti
    Chaganti
  6. Lin
    Lin
  7. Tang
    Tang
  8. Clarkson
    Clarkson
  9. Janjigian
    Janjigian
  10. Marghoob
    Marghoob

Groups

  1. Department of Medicine (279)
  2. Solid Tumor Oncology Division (160)
  3. Hematologic Malignancies, Division of (107)
  4. Center for Hematologic Malignancies (103)
  5. Survivorship Research (59)
  6. Gastrointestinal Oncology Service (57)
  7. Sloan Kettering Institute Postdocs (55)
  8. Surgery (54)
  9. Sloan Kettering Institute Faculty (47)
  10. Thoracic Oncology (45)
Search Within
Formats
  1. Meeting Abstract (332)
  2. Journal Article (254)
  3. Book Section (20)
  4. Review (15)
  5. Conference Paper (10)
  6. Book Whole (1)
  7. Editorial (1)
Groups
  1. Department of Medicine (279)
  2. Solid Tumor Oncology Division (160)
  3. Hematologic Malignancies, Division of (107)
  4. Center for Hematologic Malignancies (103)
  5. Survivorship Research (59)
  6. Gastrointestinal Oncology Service (57)

More Groups

People
  1. Lisa Bodei (32)
  2. Alexander Drilon (23)
  3. Robert Motzer (23)
  4. Ghassan Abou-Alfa (18)
  5. Steven Hajdu (18)
  6. Oscar Lin (16)

More People

Years
  1. 2025 (3)
  2. 2024 (21)
  3. 2023 (37)
  4. 2022 (42)
  5. 2021 (31)
  6. 2020 (51)

More Years

Publications
  1. Oncology Research and Treatment (226)
  2. Cytogenetics and Cell Genetics (61)
  3. Acta Cytologica (58)
  4. Neuroendocrinology (51)
  5. Acta Haematologica (32)
  6. Onkologie (19)

More Publications

Results (633)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Comparative proteomic analysis of human insulinoma and its clinical implications in pancreatic neuroendocrine tumors
    Meeting Abstract

    Qiao, X. W.; Song, Y. L.; Bai, C. M.; Zhu, L. M.; Lu, C. M.; Xiao, Y.; Chen, J.; Wang, Y. H.; Tang, L.; Yu, R.; more...
    Neuroendocrinology (2015)

    Fulltext@MSK | Save
  • Development and validation of a prognostic nomogram for progression-free survival in patients with advanced renal cell carcinoma treated with pazopanib
    Journal Article

    Kattan, M. W.; Sternberg, C. N.; Mehmud, F.; Bhatt, K.; McCann, L.; Motzer, R. J.
    Oncology (2015)

    Fulltext@MSK | Save
  • Outcomes of systemic therapy for patients with metastatic angiosarcoma
    Journal Article

    D'Angelo, S. P.; Munhoz, R. R.; Kuk, D.; Landa, J.; Hartley, E. W.; Bonafede, M.; Dickson, M. A.; Gounder, M.; Keohan, M. L.; Crago, A. M.; more...
    Oncology (2015)

    Fulltext@MSK | Save
  • Prevalence and correlates of receiving and sharing high-penetrance cancer genetic test results: Findings from the Health Information National Trends Survey
    Journal Article

    Taber, J. M.; Chang, C. Q.; Lam, T. K.; Gillanders, E. M.; Hamilton, J. G.; Schully, S. D.
    Public Health Genomics (2015)

    Fulltext@MSK | Save
  • Efficacy of idelalisib in CLL subpopulations harboring del(17p) and other adverse prognostic factors: Results from a phase 3, randomized, double-blind, placebo-controlled trial
    Meeting Abstract

    Stilgenbauer, S.; Hallek, M. J.; Coutre, S. E.; Furman, R. R.; Cheson, B. D.; Pagel, J. M.; Hillmen, P.; Barrientos, J. C.; Zelenetz, A. D.; Kipps, T. J.; more...
    Oncology Research and Treatment (2014)

    Fulltext@MSK | Save
  • Targeting Senescence-associated stemness is a conceptionally novel lymphoma treatment strategy
    Meeting Abstract

    Milanovic, M.; Dorr, J.; Dabritz, H.; Lenze, D.; Hummel, M.; Yu, Y.; Zhao, Z.; Trumpp, A.; Dorken, B.; Schmitt, C. A.
    Oncology Research and Treatment (2014)

    Fulltext@MSK | Save
  • Neoadjuvant or postoperative therapy for advanced ovarian cancer
    Meeting Abstract

    Mahner, S.; Harter, P.; Hilpert, F.; Pfisterer, J.; du Bois, A.; Chi, D.
    Oncology Research and Treatment (2014)

    Fulltext@MSK | Save
  • Synthetic lethal targeting of SUMOylation in myc-driven lymphoma
    Meeting Abstract

    Hollein, A.; Fallahi, M.; Schaub, F.; Schoeffmann, S.; Steidle, S.; Rudelius, M.; Miething, C.; Peschel, C.; Cleveland, J.; Keller, U.
    Oncology Research and Treatment (2014)

    Fulltext@MSK | Save
  • Pre-treatment with Idelalisib markedly reduces Rituximab infusion-related reactions and infusion interruptions in patients with CLL
    Meeting Abstract

    Hallek, M.; Hillmen, P.; Furman, R. R.; Coutre, S. E.; Sharman, J. P.; Pagel, J. M.; Barrientos, J. C.; Zelenetz, A. D.; Kipps, T. J.; Flinn, I. W.; more...
    Oncology Research and Treatment (2014)

    Fulltext@MSK | Save
  • 2nd analysis of a phase 3, randomized, double-blind, placebo-controlled study evaluating the efficacy and safety of Idelalisib and Rituximab for previously treated patients with chronic lymphocytic leukemia
    Meeting Abstract

    Hallek, M.; Coutre, S. E.; Furman, R. R.; Sharman, J. P.; Cheson, B. D.; Pagel, J. M.; Hillmen, P.; Barrientos, J. C.; Zelenetz, A. D.; Kipps, T. J.; more...
    Oncology Research and Treatment (2014)

    Fulltext@MSK | Save